Bepirovirsen achieves unprecedented functional cure rates with potential to redefine treatment for chronic hepatitis B gsk.com
GSK to showcase long-term outcomes and pipeline expansion with latest oncology research at ASCO and EHA gsk.com
GSK’s RSV vaccine, Arexvy, receives expanded approval in Japan for adults aged 18–59 at increased risk gsk.com
GSK enters exclusive collaboration with SBP Group, a market leader in hepatology in China, to accelerate bepirovirsen at launch gsk.com
Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA gsk.com
GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH gsk.com
Blenrep (belantamab mafodotin) approved in China for treatment of 2L+ relapsed/refractory multiple myeloma gsk.com
